170 related articles for article (PubMed ID: 31292492)
1. Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus.
Neo JYJ; Wee SYK; Bonne I; Tay SH; Raida M; Jovanovic V; Fairhurst AM; Lu J; Hanson BJ; MacAry PA
Sci Rep; 2019 Jul; 9(1):9998. PubMed ID: 31292492
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
[TBL] [Abstract][Full Text] [Related]
3. B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice.
HoHsieh A; Wang CM; Wu YJ; Chen A; Chang MI; Chen JY
Arthritis Res Ther; 2017 Mar; 19(1):65. PubMed ID: 28320458
[TBL] [Abstract][Full Text] [Related]
4. Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments.
Strang BL; Boulant S; Kirchhausen T; Coen DM
mBio; 2012; 3(1):. PubMed ID: 22318319
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.
Chang M; Pan MR; Chen DY; Lan JL
Clin Exp Immunol; 2006 Jan; 143(1):167-79. PubMed ID: 16367948
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus infection and systemic lupus erythematosus.
Rider JR; Ollier WE; Lock RJ; Brookes ST; Pamphilon DH
Clin Exp Rheumatol; 1997; 15(4):405-9. PubMed ID: 9272302
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus in patients with systemic lupus erythematosus.
Hrycek A; Kuśmierz D; Mazurek U; Wilczok T
Autoimmunity; 2005 Nov; 38(7):487-91. PubMed ID: 16373253
[TBL] [Abstract][Full Text] [Related]
8. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.
Strang BL; Boulant S; Coen DM
J Virol; 2010 Feb; 84(4):1771-84. PubMed ID: 20007282
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of DNA-binding activity of human cytomegalovirus ppUL44.
Hwang ES; Kim J; Jong HS; Park JW; Park CG; Cha CY
Microbiol Immunol; 2000; 44(10):827-32. PubMed ID: 11128066
[TBL] [Abstract][Full Text] [Related]
10. The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection.
Plachter B; Nordin M; Wirgart BZ; Mach M; Stein H; Grillner L; Jahn G
Virus Res; 1992 Aug; 24(3):265-76. PubMed ID: 1329369
[TBL] [Abstract][Full Text] [Related]
11. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
12. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.
Dolcino M; Puccetti A; Barbieri A; Bason C; Tinazzi E; Ottria A; Patuzzo G; Martinelli N; Lunardi C
Lupus; 2015 Apr; 24(4-5):419-32. PubMed ID: 25801885
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay.
Cassaniti I; Cavagna L; Calarota SA; Adzasehoun KMG; Comolli G; Montecucco C; Baldanti F
J Immunol Res; 2019; 2019():4236503. PubMed ID: 30906789
[TBL] [Abstract][Full Text] [Related]
14. Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods.
Chen J; Zhang H; Chen P; Lin Q; Zhu X; Zhang L; Xue X
Clin Rheumatol; 2015 Apr; 34(4):691-8. PubMed ID: 25750182
[TBL] [Abstract][Full Text] [Related]
15. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84.
Strang BL; Sinigalia E; Silva LA; Coen DM; Loregian A
J Virol; 2009 Aug; 83(15):7581-9. PubMed ID: 19457994
[TBL] [Abstract][Full Text] [Related]
17. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
Gergely L; Czeglédy J; Váczi L
Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
[TBL] [Abstract][Full Text] [Related]
19. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus.
Reeves WH
Rheum Dis Clin North Am; 1992 May; 18(2):391-414. PubMed ID: 1626075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
